Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Yalchin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
United European Gastroenterology Journal|November 9, 2022
Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?Ibrahim Al Bakir, Misha Kabir, Mehmet Yalchin, et al.
Cancers|July 2, 2021
Predicting Colorectal Cancer Occurrence in IBDMehmet Yalchin, Ann-Marie Baker, Trevor A Graham, et al.
Nuclear Medicine Communications|May 5, 2017
Early efficacy of and toxicity from lutetium-177-DOTATATE treatment in patients with progressive metastatic NETDeborah Pencharz, Martin Walker, Mehmet Yalchin, et al.
Clinical Nuclear Medicine|December 7, 2016
The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine TumorsMehmet Yalchin, Amelia Oliveira, Eleni Theocharidou, et al.
Therapeutic Advances in Gastroenterology|December 6, 2019
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel diseaseMehmet Yalchin, Jonathan P Segal, Benjamin H Mullish, et al.
BMJ Open|November 14, 2019
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitisMohammed Nabil Nabil Quraishi, Mehmet Yalchin, Clare Blackwell, et al.
Journal of Crohn'S & Colitis|January 26, 2026
Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trialMohammed Nabil Quraishi, Catherine A Moakes, Mehmet Yalchin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
United European Gastroenterology Journal|November 9, 2022
Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?Ibrahim Al Bakir, Misha Kabir, Mehmet Yalchin, et al.
Cancers|July 2, 2021
Predicting Colorectal Cancer Occurrence in IBDMehmet Yalchin, Ann-Marie Baker, Trevor A Graham, et al.
Nuclear Medicine Communications|May 5, 2017
Early efficacy of and toxicity from lutetium-177-DOTATATE treatment in patients with progressive metastatic NETDeborah Pencharz, Martin Walker, Mehmet Yalchin, et al.
Clinical Nuclear Medicine|December 7, 2016
The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine TumorsMehmet Yalchin, Amelia Oliveira, Eleni Theocharidou, et al.
Therapeutic Advances in Gastroenterology|December 6, 2019
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel diseaseMehmet Yalchin, Jonathan P Segal, Benjamin H Mullish, et al.
BMJ Open|November 14, 2019
STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitisMohammed Nabil Nabil Quraishi, Mehmet Yalchin, Clare Blackwell, et al.
Journal of Crohn'S & Colitis|January 26, 2026
Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trialMohammed Nabil Quraishi, Catherine A Moakes, Mehmet Yalchin, et al.
Pageof 1